Konectom Privacy Policy for Konectom, Konectom Research and Konectom NMD
Version date: May 17th, 2023
Konectom is made available to you by Biogen Digital Health, Inc.of 225 Binney Street, Cambridge, MA 02142, USA (“BDH”). To access and use Konectom and input personal data into it, you must be taking part in one of the Biogen clinical studies.
Konectom Research and Konectom NMD are made available to you by Biogen MA Inc. of 225 Binney Street, Cambridge, MA 02142, USA. To access and use these products and input personal data into them, you must be taking part in one of the Biogen clinical studies.
Unless otherwise specified, “mobile app” refers to Konectom, Konectom Research and Konectom NMD applications.
Information we collect and how we use it
To access the mobile app, the study coordinator will provide a patient ID and activation code to the clinical study participants. The mobile app does not collect any directly identifying data from users.
To access the web Dashboard/Portal, Healthcare professionals/ clinical study staff will log-in using their email address, name, surname and a password.
The mobile app and web Dashboard/Portal collect the following types of personal data for the following purposes:
| Type of collected data | Purpose |
| Data related to the participant’s medical condition (type of disease & mobility) | To configure the mobile application |
| Sensor data (IMU, microphone, screen interaction) | Mobile app only - To run the Konectom Activities |
| Relative location and GPS | Mobile app only - To run the Konectom Daily Walk |
| Smartphone details | Mobile app only - To verify compatibility |
| Patient ID and activation code | Mobile app only - To log in to the app |
| Data from Google Fit and Apple Health | Mobile app only - OPTIONAL – for research |
| Mobile app user's email address (only for Konectom) | Mobile app only - OPTIONAL – For the helpdesk only |
| Dashboard/Portal user’s email address, name and surname | Dashboard only – for account creation |
Mobile app users: To be enrolled in the study and to be able to use the mobile app, you will have signed an informed consent form (ICF) at your study site.
This ICF explains to you how your personal data is processed within the mobile app and how we use it.
Please note that the mobile app uses your relative location data to enrich the data regarding your walking capabilities.
Dashboard Users: To be enrolled in the study, your site or company must have a signed agreement with Biogen.
You may choose not to provide the requested personal information. However, if you do not provide the above information, we will not be able to provide the information as mentioned in the purpose of collection and use as stated above.
Disclosure of Personal Information to Third Parties
Your personal information collected will be shared with the Third Parties as set forth below for the clinical study:
| Third Party Recipient | Location (Country) of the recipient | Categories of Personal Information Provided | Purpose of Use of Information Provided | Period of Retention and Use of Information Provided |
| AWS | Ireland | Email address of Konectom Dashboard users | Data Collected for a Biogen Clinical study. AWS host data on behalf of PADOK | As long as required by the clinical study, according to good clinical practice. |
| Padok | France | Email address of Konectom Dashboard users | Provider of Health Data Server | As long as required by the clinical study, according to good clinical practice. |
| HCL Americas | Bulgaria | Email address of users Customer Feedback | Helpdesk provider to users | Until the end of the contract with the provider |
| Zendesk | Ireland or Germany | Email address of users Customer Feedback | Helpdesk tool to users | As required by applicable law, or as otherwise reasonable necessary for our business purposes |
Period of Retention
While enrolled and using the mobile app: As long as the account is active or as needed to provide services
Termination or Withdrawal: Should you choose to withdraw from the study or withdraw your consent, upon your request, such information will be immediately destroyed.
Subject to Applicable Law: If the retention of any information is required by applicable law, such information will be retained for the purposes and for the period prescribed by the law.
Your data rights
Your rights regarding the data you share in the clinical study, including the use of the mobile app, are detailed in the ICF. Please refer to your signed ICF to review your data rights and for information on how to exercise your rights. You may also contact your study coordinator at any time to withdraw your consent and stop using the mobile app.
Changes to This Privacy Policy
We may update this Privacy Policy from time to time. If we make any material changes, we will notify you when we do so. We advise you to review this page periodically for any changes.
Contact information
If you have questions about this Privacy Policy or use of your personal data, please contact your site using the contact details given in the ICF. You can also contact Biogen’s Data Protection Officer at privacy@biogen.com if you have general questions about data privacy at Biogen.
Contact Information – US/LATAM Insertion (Use for US & LATAM version):
If you have any concerns about the manner in which your Personal Data has been collected or handled by Biogen, or any queries in regard to this privacy notice or would like to exercise your rights as outlined in the ICF, you can contact Biogen’s Global Privacy Office at privacy@biogen.com
You can also write to the following address:
Global Privacy Office
Biogen MA Inc.
225 Binney Street
Cambridge, MA 02142
USA